QQ客服 官方微博 反馈留言

	A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PLERIXAFOR plus G-CSF VS PLACEBO plus G-CSF TO MOBILIZE a.5 X 106 CD34+CELLS/KG IN CHINESE NHL PATIENTS FOR AUTOLOGOUS TRANSPLANTATION
	Zhu, J.; Huang, H.; Chen, H.; Zhang, X.; Li, Z.; Wu, D.; Zhou, D.; Song, Y.; Hu, Y.; Liang, Y.
	2015
卷号	100页码:284-284
ISSN号	0390-6078
URL标识	查看原文
收录类别	SCIE
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6389071
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Zhu, J.,Huang, H.,Chen, H.,et al. A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PLERIXAFOR plus G-CSF VS PLACEBO plus G-CSF TO MOBILIZE a.5 X 106 CD34+CELLS/KG IN CHINESE NHL PATIENTS FOR AUTOLOGOUS TRANSPLANTATION[J],2015,100:284-284.
APA	Zhu, J..,Huang, H..,Chen, H..,Zhang, X..,Li, Z..,...&Huang, X..(2015).A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PLERIXAFOR plus G-CSF VS PLACEBO plus G-CSF TO MOBILIZE a.5 X 106 CD34+CELLS/KG IN CHINESE NHL PATIENTS FOR AUTOLOGOUS TRANSPLANTATION.,100,284-284.
MLA	Zhu, J.,et al."A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PLERIXAFOR plus G-CSF VS PLACEBO plus G-CSF TO MOBILIZE a.5 X 106 CD34+CELLS/KG IN CHINESE NHL PATIENTS FOR AUTOLOGOUS TRANSPLANTATION".100(2015):284-284.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。